Home Cart 0 Sign in  
X

[ CAS No. 884495-14-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 884495-14-1
Chemical Structure| 884495-14-1
Chemical Structure| 884495-14-1
Structure of 884495-14-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 884495-14-1 ]

Related Doc. of [ 884495-14-1 ]

Alternatived Products of [ 884495-14-1 ]

Product Details of [ 884495-14-1 ]

CAS No. :884495-14-1 MDL No. :MFCD06659504
Formula : C7H7BrN2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :BGDKJBCVNNWITN-UHFFFAOYSA-N
M.W : 247.05 Pubchem ID :40786909
Synonyms :

Calculated chemistry of [ 884495-14-1 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.29
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 52.22
TPSA : 67.94 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.36 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.7
Log Po/w (XLOGP3) : 2.04
Log Po/w (WLOGP) : 2.07
Log Po/w (MLOGP) : 1.37
Log Po/w (SILICOS-IT) : 0.34
Consensus Log Po/w : 1.5

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.87
Solubility : 0.336 mg/ml ; 0.00136 mol/l
Class : Soluble
Log S (Ali) : -3.09
Solubility : 0.199 mg/ml ; 0.000804 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.78
Solubility : 0.412 mg/ml ; 0.00167 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.3

Safety of [ 884495-14-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 884495-14-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 884495-14-1 ]
  • Downstream synthetic route of [ 884495-14-1 ]

[ 884495-14-1 ] Synthesis Path-Upstream   1~25

  • 1
  • [ 160590-36-3 ]
  • [ 884495-14-1 ]
YieldReaction ConditionsOperation in experiment
82.2% at 80℃; for 12.5 h; Sodium acetate (365 g, 5.37 mol) was added to a stirred solution of 2-methoxy-4-methyl-3-nitropyridine (250 g, 1.49 mol) in acetic acid (1 .5 L) at ambient temperature and then Br2(639 g, 4.00 mol) was added dropwise (30 mm). After addition, the mixture was heated at 80°C for 12 h, at which time TLC indicated the reaction had gone to completion. The mixturewas cooled (0 °C) and quenched by sequential addition of 10percent aqueous (1.5 L) and saturatedaqueous sodium sulfate (1.5 L). The resulting solid was collected by filtration, washed withwater, and dried under reduced pressure to give the title compound (302 g, 82.2percent yield) as alight yellow solid. h11 NMR (400 MHz, DMSO-d6): 6 8.25 (s, 1 H), 3.94 (s, 3 H), 2.29 (s, 3H).
82.2% at 80℃; for 12 h; Sodium acetate (365 g, 5.37 mol) was added to a stirred solution of 2-methoxy-4 -methyl -3- nitropyridine (250 g, 1.49 mol) in acetic acid (1.5 L) at ambient temperature and then Br2 (639 g, (0447) 4.00 mol) was added dropwise (30 min). After addition, the mixture was heated at 80 °C for 12 h, at which time TLC indicated the reaction had gone to completion. The mixture was cooled (0 (0448) °C) and quenched by sequential addition of 10percent aqueous (1.5 L) and saturated aqueous sodium sulfite (1.5 L). The resulting solid was collected by filtration washed with water, and dried under reduced pressure to give the title compound (302 g, 82.2percent yield) as a light yellow solid. (0449) NM (400 MHz, DMSO-iM): δ 8.25 (s, 1 H), 3.94 (s, 3 H), 2.29 (s, 3 H)
82.2% at 20 - 80℃; for 12 h; Sodium acetate (365 g, 5.37 mol) was added to a stirred solution of 2-methoxy-4-methyl-3- nitropyridine (250 g, 1.49 mol) in acetic acid (1.5 L) at ambient temperature and then Br2 (639 g, 4.00 mol) was added dropwise (30 min). After addition, the mixture was heated at 80 °C for 12 h, at which time TLC indicated the reaction had gone to completion. The mixture was cooled (0 °C) and quenched by sequential addition of 10percent aqueous (1.5 L) and saturated aqueous Na2S03 (1.5 L). The resulting solid was collected by filtration washed with water, and dried under reduced pressure to give the title compound (302 g, 82.2percent yield) as a light yellow solid. 1H NMR (400 MHz, DMSO-t 6): δ 8.25 (s, 1 H), 3.94 (s, 3 H), 2.29 (s, 3 H).
82.2% at 20 - 80℃; for 12 h; BrSodium acetate (365 g, 5.37 mol) was added to a stirred solution of 2-methoxy-4-methyl-3-nitropyridine (250 g, 1.49 mol) in acetic acid (1.5 L) at ambient temperature, then bromine (639g, 4.00 mol) was added and the reaction was heated at 80 °C for 12 h. The mixture was then quenched by the addition of 10percent aqueous NaOH (1.5 L) and saturated aqueous Na2SO3 (1.5 L) at 0 °C. The resulting solid was collected by filtration and washed with water, dried under vacuum to give the title compound (302 g, 82.2percent yield) as a light yellow solid. ‘H NMR (400MHz, DMSO-d6): ö 8.25 (s, 1 H), 3.94 (s, 3 H), 2.29 (s, 3 H).

Reference: [1] Patent: WO2016/77378, 2016, A1, . Location in patent: Page/Page column 85; 86; 157; 158; 163; 164
[2] Patent: WO2016/77380, 2016, A1, . Location in patent: Page/Page column 63; 64
[3] Journal of Medicinal Chemistry, 2016, vol. 59, # 11, p. 5391 - 5402
[4] Patent: WO2016/77375, 2016, A1, . Location in patent: Page/Page column 79-80
[5] Patent: WO2016/123391, 2016, A1, . Location in patent: Page/Page column 76; 77; 185; 186
  • 2
  • [ 100367-40-6 ]
  • [ 884495-14-1 ]
YieldReaction ConditionsOperation in experiment
70.44%
Stage #1: at 0℃; for 0.166667 h;
Stage #2: at 0 - 25℃; for 5 h;
Part B:; This reaction was conducted under inert gas protection. The reaction vessel was first charged with 2000 mL methanol and cooled to about 0° C. with slight agitation. Then 9.1 kg acetyl chloride was added. The exothermic reaction was then cooled and agitated for 10 minutes. The next addition was 100 g of 2-amino-5-bromo-3-nitro-4-picoline (the compound of formula 2) at 0° C. Then 236.5 g of t-butyl nitrite was added at a rate such that the temperature did not exceed 5° C. The slight evolution of nitrogen gas was noted. After the completion of the reaction, cooling was removed and the reaction mixture within the vessel was allowed to warm to 25° C. in about 30 minutes. The mixture was agitated at 25° C. for about 3-4 hours. After 4-5 hours a clear solution was obtained. Reaction completeness was monitored by HPLC after about 4 hours. The reaction was complete after about 5 hours. The reaction mixture was concentrated in vacuo to about 1000 mL. Then 500 mL of water was added and the product precipitated. Then 250 mL saturated sodium bicarbonate solution was added with good agitation to neutralize the HCl and dissolve the hydroxy impurity. The mixture was agitated at 20-25° C. for about 15 minutes and then the precipitate was collected and washed with 1000 mL of water. The product was then dried at 40° C. in vacuo. Yield was 75.0 g (70.44percent), mp. 132° C. IR (KBr, cm-1): 1633, 1581, 1538, 1512, 1458, 1377, 1344, 1321, 1244, 869, 779. 1H-NMR (DMSO-d6) (δ, ppm): 2.31 (s, 3H), 3.96 (s, 3H), 8.55 (s, 1H): 13C-NMR (DMSO-d6) (δ, ppm): 17.49, 54.91, 99.41, 114.39, 141.02, 149.23, 153.46; HMS calcd for C7H7BrN2O3 245.96401 found (M+1): 246.97184; Elemental Analysis: calcd for C7H7BrN2O3: C, 34.03; H, 2.85; N, 11.34; found: C, 33.81; H, 2.91; N, 11.24.
Reference: [1] Patent: US2006/293304, 2006, A1, . Location in patent: Page/Page column 29
  • 3
  • [ 67-56-1 ]
  • [ 100367-40-6 ]
  • [ 884495-14-1 ]
Reference: [1] Patent: US2007/32503, 2007, A1, . Location in patent: Page/Page column 9; 10-11
[2] Patent: WO2012/106189, 2012, A1, . Location in patent: Page/Page column 14
  • 4
  • [ 23056-39-5 ]
  • [ 884495-14-1 ]
Reference: [1] Patent: WO2016/77378, 2016, A1,
[2] Patent: WO2016/77380, 2016, A1,
[3] Journal of Medicinal Chemistry, 2016, vol. 59, # 11, p. 5391 - 5402
[4] Patent: WO2016/77375, 2016, A1,
[5] Patent: WO2016/123391, 2016, A1,
  • 5
  • [ 67-56-1 ]
  • [ 100367-40-6 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 6
  • [ 142404-82-8 ]
  • [ 884495-14-1 ]
Reference: [1] Patent: WO2012/106189, 2012, A1,
[2] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 7
  • [ 695-34-1 ]
  • [ 884495-14-1 ]
Reference: [1] Patent: WO2012/106189, 2012, A1,
[2] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 8
  • [ 67-56-1 ]
  • [ 100367-40-6 ]
  • [ 884495-14-1 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 9
  • [ 5327-32-2 ]
  • [ 884495-14-1 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 10
  • [ 98198-48-2 ]
  • [ 884495-14-1 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 11
  • [ 5327-32-2 ]
  • [ 884495-14-1 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 12
  • [ 5327-32-2 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 13
  • [ 142404-82-8 ]
  • [ 884495-14-1 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 14
  • [ 142404-82-8 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 15
  • [ 98198-48-2 ]
  • [ 884495-14-1 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 16
  • [ 98198-48-2 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 17
  • [ 695-34-1 ]
  • [ 884495-14-1 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 18
  • [ 695-34-1 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 19
  • [ 67-56-1 ]
  • [ 100367-40-6 ]
  • [ 124-41-4 ]
  • [ 884495-14-1 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 20
  • [ 67-56-1 ]
  • [ 100367-40-6 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 21
  • [ 5327-32-2 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 22
  • [ 142404-82-8 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 23
  • [ 98198-48-2 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 24
  • [ 695-34-1 ]
  • [ 884495-14-1 ]
  • [ 228410-90-0 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 8, p. 1095 - 1109
  • 25
  • [ 884495-14-1 ]
  • [ 1445993-26-9 ]
Reference: [1] Patent: WO2014/210425, 2014, A1,
[2] Patent: WO2014/210425, 2014, A1,
[3] Journal of Medicinal Chemistry, 2017, vol. 60, # 20, p. 8369 - 8384
[4] Journal of Medicinal Chemistry, 2017, vol. 60, # 20, p. 8369 - 8384
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 884495-14-1 ]

Bromides

Chemical Structure| 152684-30-5

[ 152684-30-5 ]

5-Bromo-2-methoxy-3-nitropyridine

Similarity: 0.91

Chemical Structure| 105544-30-7

[ 105544-30-7 ]

Ethyl 2-((5-bromo-3-nitropyridin-2-yl)oxy)acetate

Similarity: 0.81

Chemical Structure| 889943-27-5

[ 889943-27-5 ]

3-Amino-5-bromo-4-methylpyridin-2-ol

Similarity: 0.77

Chemical Structure| 884495-39-0

[ 884495-39-0 ]

5-Bromo-2-methoxypyridin-3-amine

Similarity: 0.74

Chemical Structure| 425380-37-6

[ 425380-37-6 ]

4-Bromo-7-methoxy-1H-pyrrolo[2,3-c]pyridine

Similarity: 0.74

Ethers

Chemical Structure| 152684-30-5

[ 152684-30-5 ]

5-Bromo-2-methoxy-3-nitropyridine

Similarity: 0.91

Chemical Structure| 160590-36-3

[ 160590-36-3 ]

2-Methoxy-3-nitro-4-methylpyridine

Similarity: 0.86

Chemical Structure| 105544-30-7

[ 105544-30-7 ]

Ethyl 2-((5-bromo-3-nitropyridin-2-yl)oxy)acetate

Similarity: 0.81

Chemical Structure| 20265-35-4

[ 20265-35-4 ]

2-Methoxy-3-nitropyridine

Similarity: 0.78

Chemical Structure| 33623-16-4

[ 33623-16-4 ]

2-Methoxy-3-nitropyridin-4-amine

Similarity: 0.75

Nitroes

Chemical Structure| 152684-30-5

[ 152684-30-5 ]

5-Bromo-2-methoxy-3-nitropyridine

Similarity: 0.91

Chemical Structure| 160590-36-3

[ 160590-36-3 ]

2-Methoxy-3-nitro-4-methylpyridine

Similarity: 0.86

Chemical Structure| 105544-30-7

[ 105544-30-7 ]

Ethyl 2-((5-bromo-3-nitropyridin-2-yl)oxy)acetate

Similarity: 0.81

Chemical Structure| 20265-35-4

[ 20265-35-4 ]

2-Methoxy-3-nitropyridine

Similarity: 0.78

Chemical Structure| 33623-16-4

[ 33623-16-4 ]

2-Methoxy-3-nitropyridin-4-amine

Similarity: 0.75

Related Parent Nucleus of
[ 884495-14-1 ]

Pyridines

Chemical Structure| 152684-30-5

[ 152684-30-5 ]

5-Bromo-2-methoxy-3-nitropyridine

Similarity: 0.91

Chemical Structure| 160590-36-3

[ 160590-36-3 ]

2-Methoxy-3-nitro-4-methylpyridine

Similarity: 0.86

Chemical Structure| 105544-30-7

[ 105544-30-7 ]

Ethyl 2-((5-bromo-3-nitropyridin-2-yl)oxy)acetate

Similarity: 0.81

Chemical Structure| 20265-35-4

[ 20265-35-4 ]

2-Methoxy-3-nitropyridine

Similarity: 0.78

Chemical Structure| 889943-27-5

[ 889943-27-5 ]

3-Amino-5-bromo-4-methylpyridin-2-ol

Similarity: 0.77